Table 1 Baseline demographics and clinical data

Number of subjects

16

11

–

Age (years)

47.7 ± 7.5 (34–58)

43.1 ± 7.9 (30–53)

0.15*

Women, number (%)

14 (88 %)

8 (73 %)

0.37**

Disease duration (years)

15.0 ± 10.3 (4–35)

–

–

Expanded Disability Status Scale score, median (range)

1.5 (0–2.5)

–

–

Timed 25-foot walk (seconds)

4.6 ± 0.7 (3–6)

–

–

Time on interferon β-1a (months)

68.3 ± 59.9 (4–156)

–

–